What is Chemed Corp worth?
With the base-case assumptions below, a discounted cash flow model on Chemed Corp's reported free cash flow gives $378.05 per share. The share price was $539.57 on November 10, 2026, 43% above that value.
Inputs from the filings
Three sets of assumptions
| Case | Growth yrs 1-5 | Discount rate | Value per share | Value vs price |
|---|---|---|---|---|
| Bear | -1.0% | 10.0% | $228.96 | -58% |
| Base | 4.0% | 9.0% | $378.05 | -30% |
| Bull | 9.0% | 8.0% | $656.43 | +22% |
Sensitivity: base case value per share
| 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | |
|---|---|---|---|---|---|
| 7.0% | $484.04 | $516.20 | $555.52 | $604.66 | $667.85 |
| 8.0% | $405.09 | $425.95 | $450.60 | $480.19 | $516.34 |
| 9.0% | $347.33 | $361.59 | $378.05 | $397.25 | $419.94 |
| 10.0% | $303.27 | $313.41 | $324.91 | $338.04 | $353.20 |
| 11.0% | $268.57 | $276.01 | $284.32 | $293.67 | $304.26 |
Where the presets come from
Base: years 1 to 5 grow at Chemed Corp's revenue growth rate over the last 5 fiscal years (4.0% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.
Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.
Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.
This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.
Adjust the assumptions
Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.
Adjust the assumptions